EUVIMEDEUVIMED entdecken
Crossref

Super Methotrexate-resistant Osteosarcoma Cells Retain Their Sensitivity to Recombinant Methioninase: Targeting Methionine Addiction to Overcome Extreme Cancer-Chemotherapy Resistance

Yusuke Aoki, Qinghong Han, Yutaro Kubota, Noriyuki Masaki, Yasunori Tome, Michael Bouvet, Kotaro Nishida, Robert M Hoffman

Anticancer Research · 2025

DOI: 10.21873/anticanres.17480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Yusuke Aoki und 7 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc, San Diego, CA, U.S.A.; yaoki0630@gmail.com. Hauptthemen laut MEDLINE: Methotrexate, Carbon-Sulfur Lyases, Osteosarcoma, Methionine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateCarbon-Sulfur LyasesOsteosarcomaMethionineDrug Resistance, NeoplasmBone NeoplasmsAntimetabolites, AntineoplasticHumansCell Line, TumorRecombinant ProteinsTetrahydrofolate Dehydrogenase

Stichwörter der Autor:innen

Hoffman EffectOsteosarcomamethionine addictionmethionine restrictionmethotrexaterMETaserecombinant methioninaseresistance

Substanzen

MethotrexateCarbon-Sulfur LyasesL-methionine gamma-lyaseMethionineRecombinant ProteinsAntimetabolites, AntineoplasticTetrahydrofolate Dehydrogenase

Autor:innen und Institutionen

  • AntiCancer Inc, San Diego, CA, U.S.A.; yaoki0630@gmail.com.
  • Department of Surgery, University of California, San Diego, La Jolla, CA, U.S.A.
  • Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
  • AntiCancer Inc, San Diego, CA, U.S.A.
  • Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan yastome@med.u-ryukyu.ac.jp.
  • AntiCancer Inc, San Diego, CA, U.S.A.; all@anticancer.com.

Zitieren

APA

Aoki, Y., Han, Q., Kubota, Y., Masaki, N., Tome, Y., Bouvet, M., Nishida, K., & Hoffman, R. M. (2025). Super Methotrexate-resistant Osteosarcoma Cells Retain Their Sensitivity to Recombinant Methioninase: Targeting Methionine Addiction to Overcome Extreme Cancer-Chemotherapy Resistance. Anticancer Research. https://doi.org/10.21873/anticanres.17480

Vancouver

Aoki Y, Han Q, Kubota Y, Masaki N, Tome Y, Bouvet M, et al. Super Methotrexate-resistant Osteosarcoma Cells Retain Their Sensitivity to Recombinant Methioninase: Targeting Methionine Addiction to Overcome Extreme Cancer-Chemotherapy Resistance. Anticancer Research. 2025. doi:10.21873/anticanres.17480

BibTeX
@article{Aoki2025,
  author = {Aoki, Yusuke and Han, Qinghong and Kubota, Yutaro and Masaki, Noriyuki and Tome, Yasunori and Bouvet, Michael and Nishida, Kotaro and Hoffman, Robert M},
  title = {Super Methotrexate-resistant Osteosarcoma Cells Retain Their Sensitivity to Recombinant Methioninase: Targeting Methionine Addiction to Overcome Extreme Cancer-Chemotherapy Resistance},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17480}
}
Kostenlos starten →